Literature DB >> 25948809

Genetic tools for manipulating Acinetobacter baumannii genome: an overview.

Indranil Biswas1.   

Abstract

Acinetobacter baumannii is an emerging nosocomial pathogen involved in a variety of infections ranging from minor soft-tissue infections to more severe infections such as ventilator-associated pneumonia and bacteraemia. A. baumannii has become resistant to most of the commonly used antibiotics and multidrug-resistant isolates are becoming a severe problem in the healthcare setting. In the past few years, whole-genome sequences of >200 A. baumannii isolates have been generated. Several methods and molecular tools have been used for genetic manipulation of various Acinetobacter spp. Here, we review recent developments of various genetic tools used for modification of the A. baumannii genome, including various ways to inactivate gene function, chromosomal integration and transposon mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948809     DOI: 10.1099/jmm.0.000081

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Antibiotic Combinations That Enable One-Step, Targeted Mutagenesis of Chromosomal Genes.

Authors:  Wonsik Lee; Truc Do; Ge Zhang; Daniel Kahne; Timothy C Meredith; Suzanne Walker
Journal:  ACS Infect Dis       Date:  2018-03-23       Impact factor: 5.084

3.  RNA-Mediated cis Regulation in Acinetobacter baumannii Modulates Stress-Induced Phenotypic Variation.

Authors:  Carly Ching; Kevin Gozzi; Björn Heinemann; Yunrong Chai; Veronica G Godoy
Journal:  J Bacteriol       Date:  2017-05-09       Impact factor: 3.490

4.  Effects of Inactivation of d,d-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to β-Lactam Antibiotics.

Authors:  Marta Toth; Mijoon Lee; Nichole K Stewart; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

5.  Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.

Authors:  Brian M Luna; Amber Ulhaq; Jun Yan; Paul Pantapalangkoor; Travis B Nielsen; Bryan W Davies; Luis A Actis; Brad Spellberg
Journal:  mSphere       Date:  2017-04-26       Impact factor: 4.389

6.  ERIC-PCR Genotyping of Acinetobacter baumannii Isolated from Different Clinical Specimens.

Authors:  Reem Aljindan; Khaldoon Alsamman; Nasreldin Elhadi
Journal:  Saudi J Med Med Sci       Date:  2017-12-14

Review 7.  Recent Advances in Genetic Tools for Acinetobacter baumannii.

Authors:  Ellen M E Sykes; Soumya Deo; Ayush Kumar
Journal:  Front Genet       Date:  2020-12-22       Impact factor: 4.599

8.  Role of plasmid carrying bla NDM in mediating antibiotic resistance among Acinetobacter baumannii clinical isolates from Egypt.

Authors:  Alaa Abouelfetouh; Aisha S Torky; Elsayed Aboulmagd
Journal:  3 Biotech       Date:  2020-03-16       Impact factor: 2.406

9.  Scarless Removal of Large Resistance Island AbaR Results in Antibiotic Susceptibility and Increased Natural Transformability in Acinetobacter baumannii.

Authors:  Maria-Halima Laaberki; Xavier Charpentier; Anne-Sophie Godeux; Elin Svedholm; Agnese Lupo; Marisa Haenni; Samuel Venner
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.